Dr Moisés López-González has joined the Fernandez group at Stockholm University as a postdoctoral scientist with funding from the EMI-TB project.

Moisés was awarded a PhD in Molecular Biomedicine in 2014 from the Center for Research and Advanced Studies of the National Polytechnic Institute (CINVESTAV) in Mexico City, for his thesis on innate immunity against Dengue virus infection. His next step was a postdoc at the Pasteur Institute in Paris where he studied the NK cell response against HIV infection. In his new role at SU, Moisés will study innate immunity in the respiratory tract.

The 3rd annual meeting of the EMI-TB project was held in Vigo, hosted by Africa Gonzalez-Fernandez and her team.

Several important milestones were acheived, and the meeting was a excellent opportunity to plan for the future as our project enters the next phase of delivery.

A public summary of the meeting will be available soon.

Dr Cristina Vilaplana has a PhD position available at the Unitat de Tuberculosi Experimental, part of the Fundació Insitut d'Investigació en Ciències de la Salut Germans Trias i Pujol (IGTP) in Catalonia. The project will be in tuberculosis health sciences, but with multidisciplinerary aspects including immunology, social sciences, psychology and medicine and would suit applicants with a medical background although this is not essential. For further details, see project's page on the UTE's website at https://unitatdetuberculosiexperimental.wordpress.com/2017/01/17/phd-position-do-you-want-to-work-with-us/

 

 

Prof. África González Fernández, who leads the EMI-TB workpackage on biomarkers, was one of 12 women shortlisted for the prestigious EU Prize for Women Innovators. A short video introducing her research on nanomaterials in immunological applications is available on Youtube, and more information can be found on her company's website.

TBVI logo

 

 

 

Dr Rajko Reljic and Dr Mathew Paul attended the annual general meeting of the TBVAC2020 consortium and the symposium ‘TB vaccines and Immunity’ (http://www.tbvi.eu/presentations-tbvi-symposium-tb-vaccines-and-immunity/)  in Les Diablerets, Switzerland, 1-5 February. Dr Reljic presented an update on progress of the EMI-TB project and both were invited to TBVAC2020 Steering Committee meeting to discuss future cooperation between the two consortia. Several lines of cooperation were identified with a joint late stage pre-clinical testing of the most promising vaccine candidates at the later stages of the projects being one of them.